Bayard D. Clarkson
#113,513
Most Influential Person Now
Bayard D. Clarkson's AcademicInfluence.com Rankings
Bayard D. Clarksonchemistry Degrees
Chemistry
#2263
World Rank
#3147
Historical Rank
Organic Chemistry
#332
World Rank
#398
Historical Rank
Download Badge
Chemistry
Why Is Bayard D. Clarkson Influential?
(Suggest an Edit or Addition)Bayard D. Clarkson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. (2000) (1774)
- Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). (2001) (909)
- Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase (2003) (782)
- Prognostic discrimination in "good-risk" chronic granulocytic leukemia (1984) (664)
- Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. (2007) (636)
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium (1988) (565)
- Prognostic discrimination in "good-risk" chronic granulocytic leukemia. (1984) (504)
- On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data (1993) (493)
- Control of proliferation in animal cells (1974) (482)
- Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. (1989) (408)
- p62 dok : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells (1997) (408)
- IDENTIFICATION OF HUMAN B AND T LYMPHOCYTES BY SCANNING ELECTRON MICROSCOPY (1973) (310)
- Inhibition of leukemias in man by L-asparaginase. (1967) (306)
- Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. (1980) (287)
- Toxicity of E. coli L‐asparaginase in man (1970) (287)
- A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. (1991) (249)
- AIDS‐related lymphoid neoplasia. The memorial hospital experience (1988) (239)
- Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. (1988) (233)
- L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition (2007) (233)
- Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data (1976) (226)
- Morphological Classification, Response to Therapy, and Survival in 263 Adult Patients With Acute Nonlymphoblastic Leukemia (1980) (214)
- Differentiation of normal and neoplastic hematopoietic cells (1978) (213)
- Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. (1977) (212)
- Treatment of acute leukemia in adults (1975) (212)
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol). (1979) (205)
- Treatment of adult acute leukemia with arabinosylcytosine and thioguanine (1969) (203)
- Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. (1989) (198)
- Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. (1967) (179)
- Gleevec inhibits β-amyloid production but not Notch cleavage (2003) (171)
- A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. (1999) (170)
- Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. (1982) (169)
- Acute lymphoblastic leukemia in adults. (1985) (168)
- Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. (2002) (167)
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. (1990) (162)
- Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. (1989) (160)
- Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment. (1982) (157)
- Cytogenetic and histologic correlations in malignant lymphoma. (1987) (151)
- Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor (2007) (144)
- Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay (1987) (141)
- Studies of cellular proliferation in human leukemia. III. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H‐thymidine for 8 or 10 days (1970) (140)
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. (2015) (139)
- Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. (1978) (137)
- Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. (1983) (137)
- Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. (2006) (134)
- Acute myelocytic leukemia in adults (1972) (128)
- Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens (1976) (128)
- Clinical results of treatment with E. coli L‐asparaginase in adults with leukemia, lymphoma, and solid tumors (1970) (127)
- Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. (1988) (125)
- Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. (1980) (123)
- Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. (1983) (119)
- Prophylactic heparin therapy in acute promyelocytic leukemia (1978) (113)
- Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. (1980) (109)
- Metabolism of 1- β -d-Arabinofuranosylcytosine in Human Leukemic Cells (1977) (109)
- The non‐Hodgkin's lymphomas I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969 (1983) (108)
- Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. (1989) (107)
- Continuous culture of seven new cell lines (SK‐L1 to 7) from patients with acute leukemia (1967) (105)
- Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. (1989) (102)
- P62dok, a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210bcr-abl (2001) (101)
- Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology. (1977) (100)
- Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. (2006) (100)
- Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. (1990) (98)
- A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor. (2005) (97)
- A long‐term clinical follow‐up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens (1980) (97)
- Gleevec inhibits beta-amyloid production but not Notch cleavage. (2003) (96)
- Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. (1987) (95)
- Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. (1983) (95)
- Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). (1982) (95)
- Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells. (1987) (94)
- Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma. Results of a prospective randomized study (1993) (94)
- t(3;22)(q27;q11): a novel translocation associated with diffuse non- Hodgkin's lymphoma [see comments] (1989) (94)
- Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia (1970) (93)
- Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation (2004) (90)
- Possible explanation of the high concoddance for acute leukaemia in monozygotic twins. (1971) (90)
- Predictive model for prognosis in advanced diffuse histiocytic lymphoma. (1986) (87)
- Intensive chemotherapy in children with acute lymphoblastic leukemia (L‐2 protocol) (1974) (87)
- Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring KITAY502-3ins Mutation: An In vitro Mutagenesis Screen for Drug Resistance (2009) (86)
- Changing concepts of treatment in acute leukemia. (1971) (86)
- Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. (1986) (84)
- Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia. (1980) (83)
- Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. (1985) (82)
- Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations. (1991) (81)
- Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. (1991) (78)
- Infection with human T-cell leukemia virus type I in patients with leukemia. (1988) (77)
- Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. (1983) (74)
- Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors. (2003) (74)
- Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. (1985) (73)
- Semen cryopreservation and artificial insemination for Hodgkin's disease. (1987) (73)
- The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine). (1960) (71)
- Leukemia following treatment of germ cell tumors in men. (1984) (70)
- Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variables (1982) (70)
- Acute nonlymphoblastic leukemia. Prognostic factors in adults with long‐term follow‐up (1982) (69)
- Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib (2009) (68)
- Survival in chronic myelogenous leukemia: Influence of treatment and extent of disease at diagnosis (1973) (67)
- Discordant maturation as the primary biological defect in chronic myelogenous leukemia. (1988) (67)
- Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5‐fluorouracil (1980) (66)
- Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. (1980) (65)
- Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia (1978) (64)
- Studies of cellular proliferation in human leukemia. IV. Behavior of normal hematopoietic cells in 3 adults with acute leukemia given continuous infusions of3 H‐thymidine for 8 or 10 days (1970) (63)
- Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy. (1975) (62)
- Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. (1980) (62)
- Characterization of B-cell leukemias: a tentative immunomorphological scheme. (1980) (61)
- Phosphatidylinositol 3-Kinase and Src Family Kinases Are Required for Phosphorylation and Membrane Recruitment of Dok-1 in c-Kit Signaling* (2002) (60)
- Mathematical model of granulocytopoiesis and chronic myelogenous leukemia. (1991) (60)
- The acute monocytic leukemias: multidisciplinary studies in 45 patients. (1980) (58)
- Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy. (1977) (58)
- Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. (1992) (58)
- Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. (1974) (58)
- Antimetabolite‐metabolite cancer chemotherapy using continuous intra‐arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy (1961) (58)
- Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas. (1990) (58)
- Effects of Hoechst 33342 on survival and growth of two tumor cell lines and on hematopoietically normal bone marrow cells. (1982) (58)
- Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU (1974) (57)
- Cellular Effects of Anticancer Drugs (1963) (55)
- Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase (1978) (55)
- Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. (1992) (54)
- Automated Mass Spectrometry–Based Functional Assay for the Routine Analysis of the Secretome (2013) (54)
- Cell kinetics in acute leukemia. A critical reevaluation based on new data (1982) (53)
- The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis. (1975) (51)
- The G0-G1 transition of WI38 cells. I. Laser flow microfluorimetric studies. (1977) (51)
- Quantification of change in phosphorylation of BCR‐ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells (2006) (50)
- Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment. (1987) (49)
- Detection of antibody to autologous human leukemia cells by immune adherence assays. (1977) (49)
- Quantification of the peripheral blood colony forming unit‐culture rise following chemotherapy Could leukocytaphereses replace bone marrow for autologous transplantation? (1983) (49)
- Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing. (1980) (48)
- FLOW MICROFLUOROMETRIC ANALYSIS OF CELL KILLING WITH CYTOTOXIC DRUGS (1974) (47)
- t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma. (1989) (46)
- Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing (1980) (46)
- Heterotransplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats (1969) (46)
- Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. (1986) (45)
- Angioimmunoblastic lymphadenopathy: Clinical spectrum of disease (1981) (45)
- Proliferative kinetics of central nervous system (CNS) leukemia (1975) (44)
- A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia. (1975) (43)
- Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. (1991) (43)
- Therapeutic role of cell kinetics in acute leukaemia. (1978) (42)
- Marker and kinetic studies in the non-Hodgkin's lymphomas. (1981) (42)
- Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells. (1989) (42)
- Review of recent studies of cellular proliferation in acute leukemia. (1969) (41)
- Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors. (1987) (41)
- Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation. (1983) (41)
- Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia. (1982) (41)
- Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy (1984) (40)
- Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX). (1982) (40)
- Relationship between cell type, glucose concentration, and response to treatment in neoplastic effusions (1964) (40)
- Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination (1991) (40)
- Imatinib Upregulates Compensatory Integrin Signaling in a Mouse Model of Gastrointestinal Stromal Tumor and Is More Effective When Combined with Dasatinib (2010) (39)
- Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. (1987) (39)
- The eight‐drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease. A follow‐up report (1980) (38)
- Proliferative kinetics of human hematopoietic cells during different growth phases in vitro. (1971) (37)
- Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. (1981) (37)
- Cell marker analysis in acute monocytic leukemias. (1977) (37)
- A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. (1994) (37)
- Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies. (1982) (36)
- Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years. (1986) (35)
- Treatment of immunodeficiency with interleukin-2: initial exploration. (1984) (34)
- Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. (1992) (34)
- Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. (1989) (34)
- Small Non-Cleaved-Cell Lymphoma (Undifferentiated Lymphoma, Burkitt's Type) in American Adults: Results with Treatment Designed for Acute Lymphoblastic Leukemia (1991) (34)
- 62 dok , a Negative Regulator of Ras and Mitogen-activated Protein Kinase ( MAPK ) Activity , Opposes Leukemogenesis by p 210 bcr-abl (2001) (34)
- Alternative modes of population growth inhibition in a human lymphoid cell line growing in suspension. (1977) (34)
- Stimulation of autochthonous lymphocytes by cells from normal and leukaemic lines. (1971) (33)
- Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia. (1978) (33)
- Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. (2007) (33)
- Prophylactic heparin therapy in acute promyelocytic leukemia. (1978) (33)
- Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation. (1984) (33)
- Cancer secretomes and their place in supplementing other hallmarks of cancer. (2014) (33)
- Aregenerative anemia associated with benign thymoma. (1958) (33)
- Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities (2011) (32)
- The therapy of acute granulocytic leukemia in patients more than fifty years old. (1974) (32)
- Hairy cell leukemia durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients (1985) (32)
- Prognostic Discrimination in "GoodRisk" Chronic Granulocytic Leukemia (2017) (32)
- Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. (1994) (31)
- Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells. (1988) (31)
- Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads (1988) (30)
- Duration of the dormant state in an established cell line of human hematopoietic cells. (1977) (30)
- Chromosome patterns of human leukocyte established cell lines. (1968) (30)
- Four cycles of chemotherapy and regional radiation therapy for clinical early‐stage and intermediate‐stage Hodgkin's disease (1992) (29)
- Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. (1976) (29)
- Effect of very high-dose thymidine infusions on leukemia and lymphoma patients. (1984) (29)
- Retinoic acid in acute promyelocytic leukemia: the promise and the paradox. (1991) (29)
- Electron microscopic study of human leukemic cells in tissue culture (1967) (28)
- Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. (1990) (28)
- Long‐term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group (1994) (28)
- Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material. (1982) (28)
- Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and during long-term culture in vitro. (1969) (27)
- Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature. (1986) (27)
- Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. (1987) (27)
- A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders. (2009) (27)
- Chronic myelogenous leukemia: is aggressive treatment indicated? (1985) (27)
- Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. (1992) (26)
- Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy. (1981) (26)
- 4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. (1989) (26)
- Heterogeneity of cell lineages in L3 leukemias. (1980) (25)
- TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro. (1992) (25)
- A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. (1992) (25)
- Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. (1981) (24)
- Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture. (1981) (24)
- Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. (1980) (24)
- Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia. (1982) (24)
- Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. (1984) (23)
- Formal discussion: on the cellular origins and distinctive features of cultured cell lines derived from patients with leukemias and lymphomas. (1967) (23)
- The effects of transforming growth factor β3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood (1991) (23)
- The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase. (1975) (23)
- Treatment of diffuse poorly differentiated lymphocytic lymphoma an analysis of prognostic variables (1984) (23)
- Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. (1989) (22)
- Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand. (1993) (22)
- Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. (1976) (22)
- Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). (1974) (22)
- Chronic myelogenous leukemia in an XYY male. (1982) (21)
- A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates. (2008) (21)
- Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing. (1988) (21)
- Duration of the preclinical phase of chronic myelogenous leukemia: a case report (1991) (20)
- Consideration of the Cell Cycle in Chemotherapy of Acute Leukemia (1971) (20)
- Fusarium infections in patients with hematologic malignancies. (1990) (20)
- Concanavalin A-induced suppressor cell activity in Hodgkin's disease. (1980) (19)
- The role of bone marrow aspiration and biopsy in detecting marrow involvement by nonhematologic malignancies (1976) (19)
- Clinical experience with L-asparaginase. (1970) (19)
- Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. (1991) (19)
- Cell cycle changes in ovarian cancer after arabinosylcytosine (1974) (19)
- B cells from a patient with chronic lymphocytic leukemia bind to sheep erythrocytes: an immunological analysis. (1980) (19)
- Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients (1983) (19)
- Quantitative analysis of cell cycle progression of synchronous cells by flow cytometry. (1980) (19)
- Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. (1989) (19)
- AUTOLOGOUS BONE MARROW TRANSPLANTATION USING UNFRACTIONATED CELLS WITHOUT RATE‐CONTROLLED FREEZING IN HYDROXYETHYL STARCH AND DIMETHYL SULFOXIDE (1983) (18)
- Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. (1990) (18)
- Clinical Applications of Cell Cycle Kinetics (1974) (18)
- Phorbol ester‐induced hairy cell features on chronic lymphocytic leukemia cells in vitro (1992) (18)
- NHL‐3 protocol six‐drug combination chemotherapy for non‐hodgkin's lymphoma (1984) (18)
- Current Status of Treatment of Acute Leukemia in Adults: An Overview (1984) (18)
- Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique. (1975) (18)
- Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. (1991) (17)
- Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia. (1984) (17)
- Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature. (1981) (16)
- Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells. (1981) (16)
- Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats (1969) (16)
- Photoradiation methods for purging autologous bone marrow grafts. (1990) (16)
- A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy. (1983) (16)
- Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation. (1988) (15)
- Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphoma. (1977) (15)
- ESSENTIAL MACROGLOBULINEMIA. REPORT OF A CASE INCLUDING IMMUNOFLUORESCENT AND ELECTRON MICROSCOPIC STUDIES. (1965) (15)
- Sequential Marrow Culture Studies and Terminal Deoxynucleotidyl Transferase Activities in Myelodysplastic Syndromes (1979) (15)
- Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells. (2003) (14)
- Computer analysis of tracer kinetic data from a human hematopoietic cell line during different phases of growth. (1974) (14)
- Diffuse large cell lymphoma. Prognostic factors with treatment. (1991) (14)
- Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line. (1980) (14)
- Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors. (2005) (14)
- High resolution banding of chronic myeloid leukemia chromosomes. (1986) (14)
- Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood. (1982) (14)
- Studies of cellular proliferation in human leukemia VII. Cytokinetic behavior of neoplastic cells in a patient with reticulum cell sarcoma in a leukemic phase (1971) (14)
- Studies of cellular proliferation in human leukemia VIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease (1975) (14)
- Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. (2016) (13)
- Cell kill kinetics with hydroxyurea. (1976) (13)
- Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. (1984) (13)
- Growth and development of children born to patients after cancer therapy. (1986) (13)
- Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units. (1987) (12)
- Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. (1993) (12)
- Prevention of Central Nervous System Leukaemia in Acute Lymphoblastic Leukaemia with Prophylactic Chemotherapy Alone (1979) (12)
- Plasma beta‐thromboglobulin values in thrombocytopenic patients with acute leukemia (1980) (12)
- Intensive therapy for adult acute lymphoblastic leukemia. (1991) (12)
- Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture. (1981) (12)
- Subpopulations of human T lymphocytes VI. Analysis of cell markers in acute lymphoblastic leukemia with special reference to Fc receptor expression on E‐rosette‐forming blasts (1980) (12)
- Suppression of the normal mouse c-myc oncogene in human lymphoma cells (1985) (12)
- Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester. (1979) (11)
- Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2‐anhydro‐1‐B‐D‐Arabinofuranosyl‐5‐fluorocytosine and thioguanine on the L‐12 protocol (1981) (11)
- Physical-chemical characterization of living cells by laser-flow microfluorometry. (1976) (11)
- BEHAVIOR OF P388 MOUSE LEUKEMIA IN THE CHICK EMBRYO AND HATCHED CHICK. (1964) (11)
- Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA). (1982) (11)
- 13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. (1985) (11)
- Treatment of acute myeloblastic leukaemia. (1970) (10)
- Kinetic response of human leukemic and lymphoma cells in vivo to combination chemotherapy using flow microfluorometry. (1976) (10)
- Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells. (1977) (10)
- In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation. (1989) (10)
- Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads. (1988) (10)
- Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients. (1983) (9)
- Autologous stem cell transplant for poor prognosis lymphoma (1985) (9)
- Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors. (2009) (9)
- Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias. (1979) (9)
- Factors affecting the outcome of autologous bone marrow transplantation. (1991) (9)
- Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems. (2016) (9)
- Subpopulations of human peripheral blood cells: Analysis of granulocytic progenitor cells by flow cytometry and immunologic surface markers (1979) (9)
- Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow. (1988) (9)
- Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia. (1989) (9)
- Asynchronous DNA synthesis and asynchronous mitosis in multinuclear ovarian cancer cells. (1974) (9)
- AFM study shows prominent physical changes in elasticity and pericellular layer in human acute leukemic cells due to inadequate cell–cell communication (2016) (9)
- In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamide. (1989) (8)
- Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins* (1998) (8)
- Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213. (1988) (8)
- Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease. (1982) (8)
- Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group. (1994) (8)
- Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL (2000) (8)
- Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL). (2000) (8)
- Cloning of fresh lymphoma cells. (1981) (8)
- Prognostic significance of receptors for the third component of complement an heavy chain phenotype in diffuse B-cell lymphomas. (1983) (7)
- In Vivo and in Vitro Pharmacologic Purification of Bone Marrow Contaminated with Tumor Cells Using VP16-213 and Nitrogen Mustard (1984) (7)
- The possible roles of B‐cell novel protein‐1 (BCNP1) in cellular signalling pathways and in cancer (2016) (7)
- Structural basis for the auto-inhibition of c-Abl tyrosine kinase (2003) (7)
- Duration of the preclinical phase of chronic myelogenous leukemia: a case report. (1991) (7)
- The elusive goal: presidential address. (1981) (7)
- The coexistence of acute myeloblastic leukemia and diffuse histiocytic lymphoma in the same patient as demonstrated by multiparameter analysis. (1979) (7)
- PROGRESS IN LEUKEMIAS. (1965) (7)
- Cytokinetic Resistance in Acute Leukemia: Recombinant Human Granulocyte Colony-Stimulating Factor, Granulocyte Macrophage Colony-Stimulating Factor, Interleukin-3 and Stem Cell Factor Effects In Vitro and Clinical Trials with Granulocyte Macrophage Colony-Stimulating Factor (1992) (7)
- Relationship of Auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia. (1985) (7)
- The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. (1991) (6)
- Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide. (1990) (6)
- Discussion Magnitude of Proliferating Fraction and Rate of Proliferation of Populations of Leukemic Cells in Man (1969) (6)
- Combination chemotherapy for the treatment of Hodgkin's disease in relapse (1983) (6)
- Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. (1989) (6)
- Idarubicin in acute leukemia: results of US trials. (1989) (6)
- Results of autologous bone marrow transplantation for acute leukaemia. (1989) (6)
- Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomes. (1983) (6)
- Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemia (1980) (6)
- Cell cycle changes in ovarian cancer after arabinosylcytosine. (1974) (6)
- Clinical Implications of Idarubicin Pharmacology (1992) (6)
- New pharmacologic approaches to treatment of leukemia. (1991) (6)
- The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission. (1981) (5)
- Surface Immunoglobulin Light Chain Expression in Pre‐B Cell Leukemias a (1986) (5)
- Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC). (1989) (5)
- Crystal Structure of the c-Abl Kinase domain in complex with PD173955 (2002) (5)
- Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experience. (1987) (5)
- Ex vivo treatment of myeloma cells by 4‐HC, VP‐16, LAK cells and antibodies (1989) (5)
- The training of internists in cancer. (1971) (5)
- CELL-MARKER ANALYSIS OF COMPLETE REMISSIONS IN CHRONIC B-CELL LEUKÆMIAS (1979) (5)
- Relationship of a T‐Lymphocyte marker to phase of cell cycle and morphology of leukemic cells (1977) (5)
- A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias (2004) (5)
- A prospective study of platelet‐transfusion therapy administered to patients with acute leukemia (1982) (4)
- Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells. (2016) (4)
- INACCURACY OF ESTIMATIONS OF S PHASE FRACTION BY REDUCTION IN CLONING EFFICIENCY WITH HYDROXYUREA OR TRITIATED THYMIDINE (1981) (4)
- Effects of cytosine arabinoside and daunorubicin on survival and cell cycle progression of chinese hamster ovary cells (1982) (4)
- Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia. (1988) (4)
- Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns. (1983) (4)
- Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures. (1987) (3)
- Targets for specific therapies in leukemia. (1995) (3)
- RAPID HYPOTONIC METHOD FOR FLOW CYTOFLUOROMETRY OF (1978) (3)
- Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo. (1988) (3)
- Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture. (1981) (3)
- Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells. (1983) (3)
- Allogeneic BMT for AML in Zagreb. (1989) (3)
- Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy. (1983) (3)
- Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine. (1967) (3)
- Scanning electron microscopy of human leukocytes. A comparison of air dried and critical point dried cells. (1974) (3)
- Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells. (1981) (3)
- In vitro purging with 4-hydroperoxycyclophosphamide and its effects on the hematopoietic and stromal elements of human bone marrow (1985) (2)
- Is further intensification of treatment warranted in acute nonlymphoblastic leukemia? (1983) (2)
- L-20 protocol for adult patients (pts) with acute lymphoblastic leukemia (ALL): A protocol utilizing prognostic factors, intensive chemotherapy and autologous “purged” marrow transplantation to eradicate minimal residual disease (1986) (2)
- Current concepts of leukemia and results of recent treatment programs. (1978) (2)
- Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulation. (1989) (2)
- Abstract 4117: Defective quorum sensing in Ph+ ALL and identification of diffusible factors secreted by cells growing at high cell density. (2013) (2)
- Results and prognostic factors following optimal treatment of advanced Hodgkin's disease. (1989) (2)
- Human bone marrow CFU-GM and BFU-E localized by light scatter cell sorting. (1987) (2)
- Quantitation of chemotherapy-induced cytoreduction in acute leukemia. (1981) (2)
- Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil. (1980) (2)
- Chronic Myelogenous Leukemia: Etiology, Incidence, and Clinical Features (2002) (1)
- Pseudo-Philadelphia-positive acute lymphoblastic leukemia (Ph1 + ALL) (1987) (1)
- Effect of purified fractions from cell culture supernate of high‐density pre‐B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density (2017) (1)
- The treatment of advanced hodgkin's disease (1981) (1)
- Bleomycin for treatment of immune cytopenia. (1980) (1)
- Estimation of Growth Rates of Leukemic and Normal Hematopoietic Cells in Two Adults withAcute Leukemia (1)
- Induction of giant fat cells in human bone marrow culture by human serum factor. (1981) (1)
- tumors harboring KIT AY502-3ins mutation: an in vitro mutagenesis screen for drug-resistance (2010) (1)
- Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects. (1985) (1)
- Phorbol-diester induced production of colony stimulating factor (CSF) by human myloid leukemic cells (1980) (1)
- Specific genetic defects as targets for selective therapies. Commentary. (1994) (1)
- Hetero- transplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats. (1969) (1)
- Comparative results obtained in the treatment of acute leukemia. (1973) (1)
- Non-Hodgkins lymphoma (1983) (1)
- Combination therapy involving L-asparaginase in acute leukemia. (1973) (1)
- Inhibition of recovery by actinomycin D from bleomycin-induced potentially lethal damage in a B-lymphoma cell line. (1986) (1)
- The treatment of acute nonlymphoblastic leukemia in adults. (1983) (1)
- Contents, Vol. 82, 1989 (1989) (0)
- marrow blast cell populations (see comments) Constitutive expression of p53 protein in enriched normal human (2012) (0)
- Commentary on Sandberg et al., "The In Vivo Chromosome Constitution of Marrow". (2016) (0)
- Acute Granulocytic Leukemia in Patients Over 50. (1973) (0)
- Non-Hodgkin’s lymphoma (1983) (0)
- The treatment of advanced Hodgkin's disease at Memorial Hospital. (1980) (0)
- Role of p65(dok) in leukemogenesis by p210(bcr-abl) (2000) (0)
- Results of intensive treatment of chronic myelogenous leukemia. (1981) (0)
- Treatment of acute myeloblastic leukemia. (1973) (0)
- Cytotoxic and Cytokinetic Effects of 1-/?-D-Arabinofuranosylcytosine, Daunorubicin, and 6-Thioguanine on HeLa Cells ¡nCulture1 (2006) (0)
- Growth of human bone marrow in vitro. (1985) (0)
- Contents, Vol. 80, 1988 (1988) (0)
- Philadelphia chromosome mosaicism in chronic granulocytic leukemia. (1986) (0)
- Difficulties in estimating the fraction of clonogenic cells in S phase using cloning efficiency in semi-solid medium in conjunction with cytotoxic hydroxyurea (HU) or 3H-thymidine (3H-TdR) (1979) (0)
- Chronic Myelogenous Leukemia: Prognosis and Current Status of Treatment (2002) (0)
- intensive treatment regimen (L-5 protocol) Results of treatment of Ph'+ chronic myelogenous leukemia with an (2011) (0)
- Influence of natural and immune cytotoxins on the behavior of heterotransplantable tumors in the chick. Abstr. (1960) (0)
- Consistent genetic abnormalities in human cancers as targets for selective therapies. (1992) (0)
- Adjubant chop chemotherapy following radiotherapy in stage I low and intermediate grade non-hodgkin's lymphoma: Results of a prospective randomized study (1991) (0)
- Molecular Cancer esearch aling and Regulation tinib Upregulates Compensatory Integrin Signaling in a se Model of Gastrointestinal Stromal Tumor and Is More R ctive When Combined with Dasatinib (2010) (0)
- The Novel Human Ph+ Acute Lymphoblastic Leukemia Cell Line PhALL3.1 Is Amenable to Retroviral Gene Transfer and Mimics Human Disease Progression in SCID-Beige Mice (2008) (0)
- CYCLICAL ŒDEMA AND SHOCK (1960) (0)
- [Differentiation of human normal and leukemic bone marrow and blood cells in tissue culture upon exposure to a tumor promotor]. (1979) (0)
- Mathematical model for peripheral leukocyte lowering by splenic irradiation in CML patients (1978) (0)
- The Journal thanks the following consultants who, in addition to the members of the Editorial Board, gave their time to review manuscripts submitted in 1980. (1980) (0)
- the mutation pattern for PD166326, an alternative Abl kinase inhibitor A cell-based screen for resistance of Bcr-Abl positive leukemia identifies (2012) (0)
- Combined modality therapy for advanced stage hodgkin's disease: patterns of relapse, prognostic factors and the role of radiation therapy (1990) (0)
- A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 199 Adults With Acute Lymphoblastic Leukemia (2016) (0)
- Summary overview of clinical session. (1985) (0)
- Contents, Vol. 45,1988 (1988) (0)
- cellular DNA and RNA Discrimination of human leukemia subtypes by flow cytometric analysis of (2011) (0)
- A cell-based screening method for resistance of Bcr-Abl positive leukemia identifies the mutation pattern for an alternative abl kinase inhibitor. (2004) (0)
- CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR (2000) (0)
- Subject Index, Vol. 82, 1989 (1989) (0)
- Effects of Recombinant Human Tumor Necrosis Factor on Highly Enriched Hematopoietic Progenitor Cell Populations from Normal Human Bone Marrow and Peripheral Blood and Bone Marrow from Patients with Chronic Myeloid Leukemia 1 (2006) (0)
- Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119. (1990) (0)
- [Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity]. (1983) (0)
- Complete remission of the blastic phase of chronic myelogenous leukemia (1977) (0)
- hematopoietic and microenvironmental elements of human bone marrow Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the (2011) (0)
- Chronic Myelogenous Leukemia IN VITRO STUDIES OF HEMATOPOIETIC REGULATION IN A PATIENT UNDERGOINGINTENSIVE CHEMOTHERAPY (2013) (0)
- The behavior of p388 mouse leukemia in the chick embryo and hatched chick. Abstr. (1960) (0)
- Diagnostic and Prognostic Significance of the CFU-c Assay in Acute Nonlymphoblastic Leukemia 1 (2006) (0)
- Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies. (1987) (0)
- Subject Index, Vol. 55, 1987 (1987) (0)
- Contents, Vol. 55, 1987 (1987) (0)
- Subject Index, Vol. 80, 1988 (1988) (0)
- The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia. (1978) (0)
- Thymidineas a Kineticand BiochemicalModulatorof 1-ß-D-Arabinofuranosy Icytosine in Human Acute NonlymphocyticLeukemia1 (1984) (0)
- Simplified close system unfractionated bone marrow cryo preservation using di methyl sulfoxide and hydroxyethyl starch as cryoprotectants (1981) (0)
- Modern cancer chemotherapy (1983) (0)
- Third Session Actuarial Results Comparative Results Obtained in the Treatment of Acute Leukemia (1973) (0)
- Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells. (1989) (0)
- The Elusive Goal: Presidential Address1 (2006) (0)
- [Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment]. (1980) (0)
- Colony-stimulating activity (csa) as a hormonal marker of human tumor cell lines. Csa from urinary bladder carcinoma (ubc). Abstr. (1981) (0)
- c-Kit Receptor Tyrosine Kinases Characterization of Potent Inhibitors of the Bcr-Abl and the Updated (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bayard D. Clarkson?
Bayard D. Clarkson is affiliated with the following schools:
